Profile picture

Associate Professor Thomas A Zelniker

Medical University of Vienna, Vienna (Austria)
Membership: FESC Member EACVI Member
Follow
Logo ESC

Contributor content

Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58
Presentation
Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources